Hypogammaglobulinemia secondary to B-cell depleting therapies in neuroimmunology: Comparing management strategies

Abstract

This data suggests that IVIG/SCIG may yield the greatest recovery in IgG while also reducing infection frequency and severity. Stopping anti-CD20 therapy and/or switching DMTs also increase IgG and may lower infection risk.